Erratum

In the original article by Wu, et al., entitled “Whole-Transcriptome Analysis of CD133+CD144+ Cancer Stem Cells Derived from Human Laryngeal Squamous Cell Carcinoma Cells” [Cell Physiol Biochem 2018;47(4):1696-1710, DOI: 10.1159/000490992], there have been 3 typographical errors in the title and discussion section, where “CD44+” has been written as “CD144+”.
The correct title section of the paper and the corrections of the respective sentences in the discussion section are shown below.

The authors sincerely apologize for this mistake.

Whole-Transcriptome Analysis of CD133+CD44+ Cancer Stem Cells Derived from Human Laryngeal Squamous Cell Carcinoma Cells

Yongyan Wu^a,b,c,d Yuliang Zhang^a,b,c,d Min Niu^a,b,c,d Yong Shi^a,b,c,d Hongliang Liu^a,b,c,d Dongli Yang^a,b,c,d Fei Li^a,b,c,d Yan Lu^e Yunfeng Bo Ruiping Zhang^d,g Zhenyu Li^d,h Hongjie Luo^a,b,c,d Jiajia Cui^a,b,c,d Jiangwei Sang^a,b,c,d Caixia Xiang^a,b,c,d Wei Gao^a,b,c,d Shuxin Wen^a,b,c,d

^aShanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, Taiyuan, ^bDepartment of Otolaryngology Head & Neck Surgery, The First Hospital, Shanxi Medical University, Taiyuan, ^cOtolaryngology Head & Neck Surgery Research Institute, Shanxi Medical University, Taiyuan,
^dThe Key Scientific and Technological Innovation Platform for Precision Diagnosis and Treatment of Head and Neck Cancer, Shanxi Province, Taiyuan, ^eDepartment of Otolaryngology Head & Neck Surgery, The First Hospital, Jinzhou Medical University, Jinzhou,
^fDepartment of Pathology, Shanxi Cancer Hospital, Shanxi Medical University, Taiyuan, ^gDepartment of MRI & CT, Shanxi Cancer Hospital, Shanxi Medical University, Taiyuan, hModern Research Center for Traditional Chinese Medicine, Shanxi University, Taiyuan, China

On page 1706: “Previously, we isolated CD133+CD44+ cancer stem cells from LSCC cell lines, and functional study demonstrated stronger malignant behaviors in CD133+CD44+ LSCC stem cells than CD133+ or CD44+ LSCC stem cells, CD133-CD44- LSCC cells, and parental cells [6].”